Hydroxycitric Acid: Benefits, Uses, and Side Effects

Hydroxycitric acid, commonly called HCA, is a fruit-derived compound that has been marketed for decades as a weight-loss supplement, but the clinical evidence for that use is surprisingly thin. The best available pooled analysis of randomized trials found that HCA produced less than one kilogram of extra weight loss compared to a placebo, a difference most people would struggle to notice on a bathroom scale. What makes HCA genuinely interesting, though, is the range of other biological effects researchers have documented, from shifting how the body burns fuel during exercise to potentially helping break down kidney stones. At the same time, a growing number of case reports linking Garcinia cambogia supplements to serious liver injury has put the compound under fresh scrutiny.

Where HCA Comes From

HCA is the main organic acid found in the fruit rinds of several tropical Garcinia species, particularly Garcinia cambogia (now formally Garcinia gummi-gutta), Garcinia indica, and Garcinia atroviridis.¹ The compound also occurs in Hibiscus subdariffa (roselle), though in a different stereochemical form.² The dried rinds of Garcinia fruits have been used for centuries across Southeast Asia as a souring agent in cooking, a food preservative, and a traditional digestive aid. When the supplement industry picked up on HCA in the 1990s, those rinds became the raw material for concentrated extracts standardized to a specific HCA percentage, typically sold as capsules or tablets.

How HCA Works in the Body

The mechanism that attracted the most attention is HCA’s ability to block an enzyme called ATP-citrate lyase. This enzyme is responsible for converting citrate into acetyl-CoA, a building block your body uses to manufacture fatty acids and cholesterol. By interfering with that step, HCA reduces the raw material available for fat production. Cell studies have confirmed that HCA treatment lowers both the enzyme’s protein levels and the actual concentration of acetyl-CoA in the cytoplasm, the part of the cell where fat synthesis takes place.³ Animal research has shown that this translates into lower expression of key fat-making genes and higher activity of fat-breakdown pathways, leading to reduced abdominal fat deposition in the animals studied.⁴

A second proposed mechanism involves serotonin. Laboratory work has suggested that a particular calcium-potassium salt form of HCA promotes serotonin release and inhibits its reuptake in brain tissue, which could blunt appetite.⁵ If this effect is real in humans at supplement doses, it would help explain both the modest appetite suppression some people report and, less pleasantly, the drug-interaction risk discussed later in this article.

The Weight-Loss Evidence

Given how heavily HCA has been marketed for weight loss, the clinical data is underwhelming. A systematic review and meta-analysis of randomized controlled trials found a statistically significant but small difference favoring HCA over placebo: roughly 0.88 kg of additional weight lost. The authors concluded that the clinical relevance of that effect is uncertain.⁶ To put that in everyday terms, if you took HCA for several weeks, the average extra loss compared to doing nothing different would be less than two pounds. That falls well below what most people buying a weight-loss supplement expect.

A separate meta-analysis of randomized trials looked at whether Garcinia cambogia affects leptin, a hormone that helps regulate hunger and energy balance. It found a significant reduction in leptin levels among people taking HCA compared to placebo.⁷ Lower leptin could theoretically signal the body to eat less, but the inconsistency across individual studies and the small total participant pool (around 330 people) mean this finding is far from settled.

Effects on Blood Lipids and Metabolism

The metabolic picture gets more interesting when you look beyond the scale. A meta-analysis of randomized controlled trials examining HCA’s impact on blood fats found significant reductions in total cholesterol and triglycerides, along with a modest increase in HDL (the so-called “good” cholesterol). LDL levels, however, were not meaningfully changed. The cholesterol- and triglyceride-lowering effects were more pronounced in studies lasting longer than eight weeks.⁸ A clinical study in obese subjects similarly reported reductions in body weight and improvements in triglyceride and cholesterol levels following HCA treatment.⁹

HCA also appears to influence how the body handles blood sugar, at least in healthy people. One study found that HCA supplementation lowered the insulin spike after a meal while keeping blood glucose similar, and it boosted the rate of glycogen synthesis in exercised skeletal muscle by roughly double compared to placebo. In other words, muscles stored carbohydrates more efficiently while the body simultaneously shifted toward burning more fat.¹⁰ A separate randomized trial tested HCA directly in the small intestine of both healthy people and patients with type 2 diabetes. In healthy volunteers, HCA modestly reduced blood glucose levels during fasting and after a glucose load, but in the diabetes group, no such benefit was observed.¹¹ That disconnect is a useful reminder that mechanisms demonstrated in healthy subjects do not always translate to the populations who need them most.

Exercise Performance

One of the more practical effects of HCA is its ability to shift fuel use during physical activity. A study in athletes found that short-term HCA ingestion significantly increased fat oxidation and decreased carbohydrate oxidation during moderate-intensity cycling. This glycogen-sparing effect extended the time to exhaustion after an hour of cycling.¹² Mouse studies have confirmed a similar pattern: chronic HCA administration promoted fat burning and spared carbohydrate use both at rest and during running.¹³

The logic behind this is straightforward. If HCA reduces the conversion of citrate into the building blocks for fat synthesis, that citrate may be redirected into other metabolic pathways, and the body compensates by drawing more heavily on stored fat for energy. For endurance athletes who care about glycogen sparing, the idea is appealing. The evidence is still thin, though, limited to small studies and animal work. No large trial has confirmed a meaningful performance advantage in competitive athletes.

Kidney Stones

Perhaps the most genuinely exciting area of HCA research has nothing to do with weight. Calcium oxalate stones, the most common type of kidney stone, form when oxalate crystals build up in the kidneys. Laboratory and animal studies have shown that HCA can inhibit the deposition of these crystals, reduce the adhesion of crystals to kidney tissue, and protect kidney cells from the oxidative damage that oxalate causes.¹⁴ Animal models have demonstrated that HCA reduces crystal deposits and kidney injury, with the protective effect mediated through an antioxidant defense pathway called Nrf2/Keap1.¹⁵

This research has already moved into clinical territory. A randomized, double-blind, placebo-controlled trial tested HCA as an add-on to shock wave lithotripsy, the standard procedure for breaking up kidney stones. Every patient who took HCA achieved stone fragmentation, whereas 17% of the placebo group did not.¹⁶ The trial was small, so it would be premature to call this a proven treatment, but the result is striking enough that larger studies are warranted. HCA’s dual ability to inhibit crystal formation and reduce existing crystal size positions it as an interesting candidate for both prevention and treatment of calcium oxalate stones.

Liver Injury Risk

The safety conversation around HCA has shifted considerably over the past fifteen years. Starting in 2009, European food safety authorities flagged reports of liver injury connected to Garcinia cambogia supplements, and case reports have continued to accumulate.¹⁷ A comprehensive review identified more than 200 adverse events involving liver injury from Garcinia consumption, with 34 detailed case reports. Among those, there was one death and nine liver transplants, and standardized causality assessments rated more than half as “possible” to “highly probable.”¹⁸

Data from the U.S. Drug-Induced Liver Injury Network adds important detail. Among over 1,400 enrolled patients with drug-induced liver injury, 22 cases were linked with high confidence to Garcinia cambogia, either alone or in combination with green tea or ashwagandha. The liver injury typically appeared within a few weeks to a few months of starting the supplement, was hepatocellular in nature with jaundice, and was serious enough that 91% of patients were hospitalized. One patient died and one required a liver transplant. The study also found that a specific genetic marker, the HLA-B*35:01 allele, was significantly more common in Garcinia-related cases than in liver injury from other supplements or conventional drugs.¹⁹ That genetic finding suggests some people may be biologically predisposed to this reaction, which makes the risk unpredictable for any individual consumer.

A complicating factor is that many Garcinia supplements contain other ingredients, particularly green tea extract, which itself has a well-documented association with liver toxicity. Disentangling which ingredient caused the injury in a given case is often impossible. Still, the cases involving Garcinia alone, while fewer, exist and cannot be dismissed. If you have any history of liver problems, avoiding HCA supplements is the prudent call.

Drug Interactions and Serotonin Toxicity

The serotonin-related mechanism described earlier creates a real and underrecognized danger. A published case report documented serotonin toxicity, a potentially life-threatening condition involving agitation, rapid heart rate, high blood pressure, and muscle rigidity, resulting from the combination of a Garcinia cambogia supplement and a prescribed antidepressant in the SSRI class.²⁰ Because HCA may promote serotonin release and inhibit its reuptake, layering it on top of a serotonergic drug can push serotonin levels dangerously high. Anyone taking an SSRI, SNRI, tricyclic antidepressant, or other medication that raises serotonin should avoid HCA supplements entirely. Most product labels do not warn about this interaction, which makes it easy to overlook.

Dosage and the Safety Ceiling

Toxicology reviews have placed the no-observed-adverse-effect level for HCA in humans at up to 2,800 mg per day based on both animal data and human use history.²¹ A 90-day rat study of the calcium-potassium salt form at high doses found decreases in body weight and food intake but no adverse effects within that dose window.²² However, animal research also revealed a dose-dependent risk at very high intakes: in young male rats, diets with very high concentrations of HCA caused severe testicular atrophy and toxicity, while lower doses did not.²³ The testicular toxicity at those extreme doses is unlikely to be relevant at the amounts found in commercial supplements, but it highlights that HCA is not pharmacologically inert and that “natural” does not mean “safe at any dose.”

The form of HCA matters for how much actually enters your bloodstream. A pharmacokinetic comparison in rats found that the calcium-potassium double salt form achieved roughly triple the peak blood concentration and about double the overall bioavailability compared to the plain calcium salt.²⁴ This means two supplements with identical HCA content on the label can deliver very different amounts into the body depending on the salt form used.

Supplement Quality Problems

Even assuming HCA is safe at the dose you intend to take, you may not be getting that dose. Independent analyses of Garcinia cambogia supplements have repeatedly found discrepancies between what the label claims and what the capsule contains. One study detected mismatches in a third of the samples tested, with some products containing far less HCA than declared.²⁵ A separate analysis using DNA barcoding and chemical fingerprinting found even more dramatic shortfalls: two products claiming 60% HCA content actually contained only about 5% of the expected amount.²⁶ Undeclared compounds not naturally present in Garcinia fruit were also detected, likely introduced during manufacturing or from unlisted additives.

This quality-control problem is not unique to HCA supplements, but it carries particular implications here. If you are relying on a specific dose to stay below the safety ceiling, or to match the dose ranges used in clinical trials, a product that delivers three times more or five times less than labeled makes any risk-benefit calculation meaningless. Third-party testing certifications (USP, NSF, ConsumerLab) are the most reliable way to verify what is actually in a supplement, but many Garcinia products on the market do not carry them.

Laboratory Research on Liver Fat

While the liver injury cases rightly dominate the safety discussion, a parallel line of laboratory research has been examining whether HCA might actually protect liver cells under certain conditions. Cell studies have found that HCA can reduce fat accumulation in hepatocytes exposed to oleic acid, a model of fatty liver disease, by activating an energy-sensing pathway called AMPK.²⁷ An animal study in rats fed a high-fat diet found that a combination of HCA and capsaicin improved insulin sensitivity, suppressed fat-building gene activity in the liver, and reduced inflammation and oxidative stress through multiple signaling pathways.²⁸

The apparent contradiction between “HCA causes liver injury in some people” and “HCA protects liver cells in the lab” is not unusual in pharmacology. Many compounds are beneficial at one dose or context and harmful at another, or they affect different people differently because of genetic variation. The HLA genetic marker identified in liver injury cases may represent a susceptibility that turns an otherwise tolerable compound into a damaging one for a subset of the population. Until screening for that marker becomes routine, which it is nowhere close to being, the safest approach is to treat the liver injury signal seriously regardless of the lab data suggesting protective potential.